Improved cytotoxicity and multidrug resistance reversal of chitosan based polymeric micelles encapsulating oxaliplatin

References

• Abulrob AN, Mason M, Bryce R, Gumbleton M. (2000). The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance. J Drug Target, 8, 247–256.
   PubMed Web of Science ®Google Scholar
• Beretta GL, Benedetti V, Cossa G, Assaraf YG, Bram E, Gatti L, Corna E, Carenini N, Colangelo D, Howell SB, Zunino F, Perego P. (2010). Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin. Biochem Pharmacol, 79, 1108–1117.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Krajicek ME. (1998). Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J Control Release, 50, 215–223.
   PubMed Web of Science ®Google Scholar
• Brabec V, Kasparkova J. (2005). Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs. Drug Resist Updat, 8, 131–146.
   PubMed Web of Science ®Google Scholar
• Burchenal JH, Holmberg EA. (1958). The utility of resistant leukemias in screening for chemotherapeutic activity. Ann N Y Acad Sci, 76, 826–31; discussion 832.
   PubMed Web of Science ®Google Scholar
• Cabral H, Nishiyama N, Kataoka K. (2007). Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity. J Control Release, 121, 146–155.
   PubMed Web of Science ®Google Scholar
• Cunningham D, Littleford RE, Smith WE, Lundahl PJ, Khan I, McComb DW, Graham D, Laforest N. (2006). Practical control of SERRS enhancement. Faraday Discuss, 132, 135–45; discussion 147.
   PubMed Web of Science ®Google Scholar
• Extra JM, Espie M, Calvo F, Ferme C, Mignot L, Marty M. (1990). Phase I study of oxaliplatin in patients with advanced cancer. Cancer Chemother Pharmacol, 25, 299–303.
   PubMed Web of Science ®Google Scholar
• Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. (2005). Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release, 109, 169–188.
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Pastan I, Ambudkar SV. (1996). P-glycoprotein and multidrug resistance. Curr Opin Genet Dev, 6, 610–617.
   PubMed Web of Science ®Google Scholar
• Greish K. (2007). Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target, 15, 457–464.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Jiang XH, Huang X, Wu XL, Yuan H, Wei XH, Du YZ. (2009). Enhanced cellular uptake of chlorine e6 mediated by stearic acid-grafted chitosan oligosaccharide micelles. J Drug Target, 17, 384–391.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Wu XL, Du YZ, You J, Yuan H. (2008). Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. Eur J Pharm Biopharm, 69, 117–125.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Zhao MD, Yuan H, You J, Du YZ, Zeng S. (2006). A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. Int J Pharm, 315, 158–166.
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. (2002). Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev, 54, 759–779.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, Jo HG, Park JH, Choi K, Jeong SY, Park RW, Kim IS, Kim K, Kwon IC. (2008). Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release, 127, 41–49.
   PubMed Web of Science ®Google Scholar
• Kintzel PE. (2001). Anticancer drug-induced kidney disorders. Drug Saf, 24, 19–38.
   PubMed Web of Science ®Google Scholar
• Kotzé AF, Luessen HL, de Boer AG, Verhoef JC, Junginger HE. (1999). Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. Eur J Pharm Sci, 7, 145–151.
   PubMed Web of Science ®Google Scholar
• Kwon GS, Okano T. (1996). Polymeric micelles as new drug carriers. Adv Drug Deliv Rev, 21, 107–116.
   Web of Science ®Google Scholar
• Liu SQ, Wiradharma N, Gao SJ, Tong YW, Yang YY. (2007). Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials, 28, 1423–1433.
   PubMed Web of Science ®Google Scholar
• Mahmud A, Xiong XB, Aliabadi HM, Lavasanifar A. (2007). Polymeric micelles for drug targeting. J Drug Target, 15, 553–584.
   PubMed Web of Science ®Google Scholar
• Malmsten M, Lindman B. (1992). Self-assembly in aqueous block copolymer solutions. Macromolecules, 25, 5440–5445.
   Web of Science ®Google Scholar
• Mohajer G, Lee ES, Bae YH. (2007). Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells. Pharm Res, 24, 1618–1627.
   PubMed Web of Science ®Google Scholar
• Molina-Bolívar JA, Hierrezuelo JM, Carnero Ruiz C. (2007). Self-assembly, hydration, and structures in N-decanoyl-N-methylglucamide aqueous solutions: effect of salt addition and temperature. J Colloid Interface Sci, 313, 656–664.
   PubMed Web of Science ®Google Scholar
• Narasaki F, Matsuo I, Ikuno N, Fukuda M, Soda H, Oka M. (1996). Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. Anticancer Res, 16, 2079–2082.
   PubMed Web of Science ®Google Scholar
• Nishiyama N, Kataoka K. (2001). Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core. J Control Release, 74, 83–94.
   PubMed Web of Science ®Google Scholar
• Potineni A, Lynn DM, Langer R, Amiji MM. (2003). Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. J Control Release, 86, 223–234.
   PubMed Web of Science ®Google Scholar
• Teodori E, Dei S, Scapecchi S, Gualtieri F. (2002). The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Farmaco, 57, 385–415.
   PubMedGoogle Scholar
• Viale M, Minetti S, Ottone M, Lerza R, Parodi B, Pannacciulli I. (2003). Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR. Anticancer Drugs, 14, 163–166.
   PubMed Web of Science ®Google Scholar
• You J, Hu FQ, Du YZ, Yuan H. (2007). Polymeric micelles with glycolipid-like structure and multiple hydrophobic domains for mediating molecular target delivery of paclitaxel. Biomacromolecules, 8, 2450–2456.
   PubMed Web of Science ®Google Scholar